PT
Philip Thompson
Hematology & Oncology
Credentials: ·
History
- 2016–2019
Hematology and Medical Oncology
- 2013–2016
Internal Medicine
- 1999–2003
Medical School
Research
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
New England Journal of Medicine · 2020 · 1,804 citations
Ibrutinib and Venetoclax for First-Line Treatment of CLL
New England Journal of Medicine · 2019 · 426 citations
Blood · 2016 · First of 10 authors · 423 citations
67 papers · 2 as a fellow
57 papers
55 papers
- MK
45 papers
43 papers
41 papers
- ZE
35 papers
29 papers
